• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视力损害和失明造成的全球经济生产力损失。

Global economic productivity losses from vision impairment and blindness.

作者信息

Marques Ana Patricia, Ramke Jacqueline, Cairns John, Butt Thomas, Zhang Justine H, Muirhead Debbie, Jones Iain, Tong Brandon A M Ah, Swenor Bonnielin K, Faal Hannah, Bourne Rupert R A, Frick Kevin D, Burton Matthew J

机构信息

London School of Hygiene & Tropical Medicine, London WC1E 7HT, United Kingdom.

School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand.

出版信息

EClinicalMedicine. 2021 Apr 26;35:100852. doi: 10.1016/j.eclinm.2021.100852. eCollection 2021 May.

DOI:10.1016/j.eclinm.2021.100852
PMID:33997744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8093883/
Abstract

BACKGROUND

In the absence of accessible, good quality eye health services and inclusive environments, vision loss can impact individuals, households and communities in many ways, including through increased poverty, reduced quality of life and reduced employment. We aimed to estimate the annual potential productivity losses associated with reduced employment due to blindness and moderate and severe vision impairment (MSVI) at a regional and global level.

METHODS

We constructed a model using the most recent economic, demographic (2018) and prevalence (2020) data. Calculations were limited to the working age population (15-64 years) and presented in 2018 US Dollars purchasing power parity (ppp). Two separate models, using Gross Domestic Product (GDP) and Gross National Income (GNI), were calculated to maximise comparability with previous estimates.

FINDINGS

We found that 160.7 million people with MSVI or blindness were within the working age and estimated that the overall relative reduction in employment by people with vision loss was 30.2%. Globally, using GDP we estimated that the annual cost of potential productivity losses of MSVI and blindness was $410.7 billion ppp (range $322.1 - $518.7 billion), or 0.3% of GDP. Using GNI, overall productivity losses were estimated at $408.5 billion ppp (range $320.4 - $515.9 billion), 0.5% lower than estimates using GDP.

INTERPRETATION

These findings support the view that blindness and MSVI are associated with a large economic impact worldwide. Reducing and preventing vision loss and developing and implementing strategies to help visually impaired people to find and keep employment may result in significant productivity gains.

FUNDING

MJB is supported by the Wellcome Trust (207472/Z/17/Z). JR's appointment at the University of Auckland is funded by the Buchanan Charitable Foundation, New Zealand. The Commission on Global Eye Health was supported by grants from The Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity (GR001061), NIHR Moorfields Biomedical Research Centre, The Wellcome Trust, Sightsavers, The Fred Hollows Foundation, The SEVA Foundation, The British Council for the Prevention of Blindness and Christian Blind Mission. The funders had no role in the design, conduct, data analysis of the study, or writing of the manuscript.

摘要

背景

在缺乏可及的、高质量的眼健康服务和包容性环境的情况下,视力丧失会在许多方面影响个人、家庭和社区,包括导致贫困加剧、生活质量下降和就业机会减少。我们旨在估计在区域和全球层面上,因失明以及中度和重度视力障碍(MSVI)导致就业减少所带来的年度潜在生产力损失。

方法

我们使用最新的经济、人口统计学(2018年)和患病率(2020年)数据构建了一个模型。计算仅限于工作年龄人口(15 - 64岁),并以2018年美元购买力平价(PPP)呈现。使用国内生产总值(GDP)和国民总收入(GNI)分别构建了两个独立模型,以最大限度地与先前的估计进行比较。

研究结果

我们发现,1.607亿患有MSVI或失明的人处于工作年龄,并估计视力受损者的总体就业相对减少了30.2%。在全球范围内,使用GDP我们估计MSVI和失明导致的年度潜在生产力损失成本为4107亿美元PPP(范围为3221亿 - 5187亿美元),占GDP的0.3%。使用GNI,总体生产力损失估计为4085亿美元PPP(范围为3204亿 - 5159亿美元),比使用GDP的估计低0.5%。

解读

这些发现支持了这样一种观点,即失明和MSVI在全球范围内具有巨大的经济影响。减少和预防视力丧失,以及制定和实施策略来帮助视障人士找到并维持就业,可能会带来显著的生产力提升。

资金来源

MJB由惠康信托基金(207472/Z/17/Z)资助。JR在奥克兰大学的职位由新西兰布坎南慈善基金会资助。全球眼健康委员会得到了伊丽莎白女王钻石禧年信托基金、摩尔菲尔德眼科慈善机构(GR001061)、NIHR摩尔菲尔德生物医学研究中心、惠康信托基金、防盲救盲组织、弗雷德·霍洛基金会、SEVA基金会、英国预防失明理事会和基督教盲人传教团的资助。资助者在研究的设计、实施过程、数据分析或稿件撰写方面没有任何作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/8093883/3010cf2d651e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/8093883/ba08e14e55e1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/8093883/3010cf2d651e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/8093883/ba08e14e55e1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/8093883/3010cf2d651e/gr2.jpg

相似文献

1
Global economic productivity losses from vision impairment and blindness.视力损害和失明造成的全球经济生产力损失。
EClinicalMedicine. 2021 Apr 26;35:100852. doi: 10.1016/j.eclinm.2021.100852. eCollection 2021 May.
2
The Economic Impact of Blindness in Europe.欧洲失明问题的经济影响。
Ophthalmic Epidemiol. 2017 Aug;24(4):239-247. doi: 10.1080/09286586.2017.1281426. Epub 2017 Jun 30.
3
Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally.全球实施现有解决方案对近距和远距离视力损伤的三十年预测规模(到 2050 年)及其经济影响。
Ophthalmic Epidemiol. 2020 Apr;27(2):115-120. doi: 10.1080/09286586.2019.1700532. Epub 2019 Dec 6.
4
Update of a Simple Model to Calculate the Annual Global Productivity Loss Due to Blindness and Moderate and Severe Vision Impairment.一个用于计算因失明以及中度和重度视力损害导致的年度全球生产力损失的简单模型的更新
Ophthalmic Epidemiol. 2022 May 24:1-9. doi: 10.1080/09286586.2022.2072899.
5
A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment.一种估算因失明及中度至重度视力损害导致的生产力损失经济成本的简单方法。
Ophthalmic Epidemiol. 2015;22(5):349-55. doi: 10.3109/09286586.2015.1066394.
6
Association between vision impairment and mortality: a systematic review and meta-analysis.视力障碍与死亡率的关联:系统评价和荟萃分析。
Lancet Glob Health. 2021 Apr;9(4):e418-e430. doi: 10.1016/S2214-109X(20)30549-0. Epub 2021 Feb 16.
7
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
8
Grand Challenges in global eye health: a global prioritisation process using Delphi method.全球眼健康重大挑战:应用德尔菲法的全球优先排序过程。
Lancet Healthy Longev. 2022 Jan;3(1):e31-e41. doi: 10.1016/S2666-7568(21)00302-0.
9
The economic and social costs of visual impairment and blindness in India.印度视力障碍和失明的经济和社会成本。
Indian J Ophthalmol. 2022 Oct;70(10):3470-3475. doi: 10.4103/ijo.IJO_502_22.
10
The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.全球未矫正老视导致的潜在生产力损失负担。
Ophthalmology. 2015 Aug;122(8):1706-10. doi: 10.1016/j.ophtha.2015.04.014.

引用本文的文献

1
Combined effects of visual impairment and chronic kidney disease on all-cause mortality among middle-aged and older adults: a longitudinal, population-based cohort study in China.视力损害与慢性肾脏病对中老年人群全因死亡率的联合影响:一项基于中国人群的纵向队列研究
BMJ Open. 2025 Sep 3;15(9):e098553. doi: 10.1136/bmjopen-2024-098553.
2
Global, Regional, and National Burden of Blindness due to Diabetic Retinopathy, 1990-2021.1990 - 2021年糖尿病性视网膜病变导致的全球、区域和国家失明负担
Ophthalmol Ther. 2025 Aug 27. doi: 10.1007/s40123-025-01230-y.
3
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World Practice.

本文引用的文献

1
Advancing the Sustainable Development Goals through improving eye health: a scoping review.通过改善眼健康推进可持续发展目标:范围综述。
Lancet Planet Health. 2022 Mar;6(3):e270-e280. doi: 10.1016/S2542-5196(21)00351-X. Epub 2022 Feb 25.
2
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.《柳叶刀》全球眼健康委员会:2020年之后的愿景。
Lancet Glob Health. 2021 Apr;9(4):e489-e551. doi: 10.1016/S2214-109X(20)30488-5. Epub 2021 Feb 16.
3
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.
糖尿病性黄斑水肿治疗的成本效益:模拟的贝伐单抗初始治疗与实际临床实践对比
J Vitreoretin Dis. 2025 Aug 11:24741264251359888. doi: 10.1177/24741264251359888.
4
Myopia Management in Ontario, Canada.加拿大安大略省的近视管理
J Clin Med. 2025 Jul 19;14(14):5132. doi: 10.3390/jcm14145132.
5
Association between dietary magnesium intake and risk of cataract surgery: data from NHANES 2003-2008.饮食中镁摄入量与白内障手术风险之间的关联:来自2003 - 2008年美国国家健康与营养检查调查(NHANES)的数据。
Eye (Lond). 2025 Jul 23. doi: 10.1038/s41433-025-03930-y.
6
Global trends and disparities in burden of blindness and vision loss caused by non-communicable diseases from 1990 to 2021, and forecasts to 2045: a systematic analysis for the global burden of disease study 2021.1990年至2021年非传染性疾病所致失明和视力丧失负担的全球趋势与差异,以及到2045年的预测:全球疾病负担研究2021的系统分析
Front Med (Lausanne). 2025 Jun 19;12:1561568. doi: 10.3389/fmed.2025.1561568. eCollection 2025.
7
Remote Eye Triage: Health Economic Perspectives on Resource Prioritization.远程眼科分诊:资源优先排序的卫生经济学视角
Health Serv Insights. 2025 Jun 26;18:11786329251347684. doi: 10.1177/11786329251347684. eCollection 2025.
8
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
9
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America.抗血管内皮生长因子对英国、欧洲和北美的患者及护理人员造成的经济负担。
Ophthalmol Ther. 2025 Jun 28. doi: 10.1007/s40123-025-01180-5.
10
Prevalence of vision impairment among patients with diabetes mellitus in sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区糖尿病患者视力损害的患病率:一项系统评价和荟萃分析。
PLoS One. 2025 Jun 24;20(6):e0326176. doi: 10.1371/journal.pone.0326176. eCollection 2025.
30 多年来盲症和远距离及近距离视力损伤流行率的变化趋势:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.
4
Eye health and quality of life: an umbrella review protocol.眼健康和生活质量:伞式综述方案。
BMJ Open. 2020 Aug 30;10(8):e037648. doi: 10.1136/bmjopen-2020-037648.
5
Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally.全球实施现有解决方案对近距和远距离视力损伤的三十年预测规模(到 2050 年)及其经济影响。
Ophthalmic Epidemiol. 2020 Apr;27(2):115-120. doi: 10.1080/09286586.2019.1700532. Epub 2019 Dec 6.
6
Productivity Losses and Their Explanatory Factors Amongst People with Impaired Vision.视力受损人群的生产力损失及其解释因素
Ophthalmic Epidemiol. 2019 Dec;26(6):378-392. doi: 10.1080/09286586.2019.1632904. Epub 2019 Jul 8.
7
Association of visual acuity with educational outcomes: a prospective cohort study.视力与教育成果的关系:一项前瞻性队列研究。
Br J Ophthalmol. 2019 Nov;103(11):1666-1671. doi: 10.1136/bjophthalmol-2018-313294. Epub 2019 Jan 18.
8
Potential Lost Productivity Resulting from the Global Burden of Myopia: Systematic Review, Meta-analysis, and Modeling.全球近视负担导致的潜在生产力损失:系统评价、荟萃分析和建模。
Ophthalmology. 2019 Mar;126(3):338-346. doi: 10.1016/j.ophtha.2018.10.029. Epub 2018 Oct 17.
9
Effect of providing near glasses on productivity among rural Indian tea workers with presbyopia (PROSPER): a randomised trial.提供近用眼镜对印度农村远视茶农生产力的影响(PROSPER):一项随机试验。
Lancet Glob Health. 2018 Sep;6(9):e1019-e1027. doi: 10.1016/S2214-109X(18)30329-2. Epub 2018 Jul 23.
10
The Economic Burden of Visual Impairment and Comorbid Fatigue: A Cost-of-Illness Study (From a Societal Perspective).视觉障碍与共病性疲劳的经济负担:一项疾病成本研究(从社会角度来看)。
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1916-1923. doi: 10.1167/iovs.17-23224.